Navigation Links
Sugary Sodas High in Diabetes-Linked Compound
Date:8/24/2007

, diabetes and metabolism at Beth Israel Deaconess Medical Center in Boston, agreed that Ho's study "needs to be validated by other studies" before definitive conclusions can be drawn.

"However, given the marked prevalence of obesity and type 2 diabetes in our society, and the accompanying risks for cardiovascular disease, there is no reason related to health to drink beverages sweetened with high fructose corn syrup," said Kahn, who is also a professor of medicine at Harvard University.

"In general, it would be healthier to avoid most high-calorie beverages as part of a program to prevent obesity," she added. "There may be added reasons to avoid beverages with HFCS."

More information

Read the U.S. government's Dietary Guidelines for Americans.



SOURCES: Chi-Tang Ho, Ph.D., professor, food science, Rutgers University, New Brunswick, N.J.; Lona Sandon, R.D., assistant professor, clinical nutrition, University of Texas Southwestern Medical Center at Dallas, and spokeswoman, American Dietetic Association; Barbara B. Kahn, M.D., chief, division of endocrinology, diabetes and metabolism, Beth Israel Deaconess Medical Center, and professor, medicine, Harvard Medical School, Boston; presentation, Aug. 23, 2007, American Chemical Society annual meeting, Boston


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. A simple answer to teen weight loss: Reducing sugary drinks
2. Soda and Sugary Drinks make Americans Obese
3. Sugary Beverages Fuel the Obesity Epidemic
4. Sugary drinks increase Pancreatic cancer risk
5. Sugary News for Diabetics – Cure Stems from Stem Cell Therap
6. Sugary Foods Turn Kids Teeth Rotten in US
7. High-fat and Sugary Diet Severely Damage Liver and Other Vital Organs
8. Sugary Diet can Be Helpful in Shedding Off Pounds
9. Common Ingredient in Big Macs and Sodas Can Stabilize Gold Nanoparticles for Medical Use
10. Compound of Broccoli combats breast cancer
11. Brain cells protected by new compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)PALO ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: VAR ) announced today that its Board of Directors has set the regular 2010 Annual Meeting of Stockholders for February 11, 2010 with a record
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
(Date:12/4/2009)Increasing exercise, water and fruit consumption leads to success, study finds , , FRIDAY, Dec. 4 (HealthDay News) -- Increased exercise, reduced soda consumption and self-weighing are among
Breaking Medicine News(10 mins):Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Teens Lose More Weight Using Healthy Strategies 2
...new study appearing in the February 22 issue of th...d no significant differences in the effectiveness ...s or paclitaxel. Drug-releasing stents are known t...or the outcome of procedures like angioplasty, whe...
...rthwestern Memorial Hospital along with Northweste...cting a Phase II clinical trial to determine if av... drug also known as bevacizumab is an anti-angioge...radiation therapy and chemotherapy can reduce loca...
...e ripple effect caused by the bird flu threat has ...vable 60 percent down in the Indian capital. One c...eing sold for just Rs. 12 per kg. // Only th...ified was available for a mere Rs.12 per kg. ...
...e first ever-cervical cancer vaccine, Gardasil is ...ting females between 9 and 24 years of age. // Soo...s to prevent them from infecting their sexual part...r prevention. Most cases of cervical cancer can be...
...ndon: European Union has a huge health problem of...er one health ailment in the Union, that costed th...2003, according to a study. // Take a look at...e costs, per person. As a consequence, absenteeism...
...e SRY or the sex determination gene, that plays a ...op into a male or female (embryo with SRY gene dev...ce of Parkinson's disease in men. // The SRY prote... University of California. The SRY gene was ...
Other Medicine News:Health News:Avastin under trial to test efficacy for pancreatic tumours! 2Health News:Delhi Sees Sharp Decline In Chicken Prices 2Health News:Delhi Sees Sharp Decline In Chicken Prices 3Health News:Men Might Get Their Share of Cervical Cancer Vaccine As Well 2Health News:Sex Determination Gene Blamed For High Incidence Of Parkinson’s In Me 2
(Date:12/4/2009)MORRISTOWN, N.J., Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed
(Date:12/4/2009)RARITAN, N.J., Dec. 4 Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur
(Date:12/3/2009)SUNNYVALE, Calif., Dec. 3 Pharmacyclics, Inc. (Nasdaq: PCYC ), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune media
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Hospira Acquires TheraDoc Enhances Medication Safety and Infection Management Offerings 6681 1Hospira Acquires TheraDoc Enhances Medication Safety and Infection Management Offerings 6681 2Hospira Acquires TheraDoc Enhances Medication Safety and Infection Management Offerings 6681 3Hospira Acquires TheraDoc Enhances Medication Safety and Infection Management Offerings 6681 4Hospira Acquires TheraDoc Enhances Medication Safety and Infection Management Offerings 6681 5Distrust of men doesnt stall low income mothers romantic unions 62447 1Young adults who exercise get higher IQ 10960 1Young adults who exercise get higher IQ 10960 2
...BUDAPEST, Hungary and EXTON, Pa., May 26 ViroPhar...the presentation of five abstracts relating to Cin...t the 6th Annual C1 Inhibitor Deficiency Workshop....rug Administration in October 2008 for routine pro...ks in adults and adolescents. In February 2009, Vi...
...Data Confirm Tapentadol Efficacy and Tolerability ... It is estimated that up to 30 percent of all peo...ide effects, such as nausea and vomiting. The use ...is a leading risk factor for experiencing these si...and bothersome and can have an impact on a patient...
Other Medicine Technology:Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop 2Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop 3Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop 4Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop 5Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop 6Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop 7New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 2New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 3New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 4New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 5New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 6New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 7New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 8
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: